UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,409 | -89.3% | 508 | -81.7% | 0.00% | – |
Q2 2023 | $31,790 | -36.7% | 2,774 | +11.3% | 0.00% | – |
Q1 2023 | $50,189 | -11.8% | 2,492 | -0.7% | 0.00% | – |
Q4 2022 | $56,878 | +35.4% | 2,509 | +11.4% | 0.00% | – |
Q3 2022 | $42,000 | +200.0% | 2,253 | +194.1% | 0.00% | – |
Q2 2022 | $14,000 | -62.2% | 766 | -62.4% | 0.00% | – |
Q1 2022 | $37,000 | +131.2% | 2,038 | +152.5% | 0.00% | – |
Q4 2021 | $16,000 | -81.4% | 807 | -70.3% | 0.00% | – |
Q3 2021 | $86,000 | +514.3% | 2,720 | +515.4% | 0.00% | – |
Q2 2021 | $14,000 | +7.7% | 442 | +10.8% | 0.00% | – |
Q1 2021 | $13,000 | -13.3% | 399 | -5.0% | 0.00% | – |
Q4 2020 | $15,000 | -6.2% | 420 | -5.8% | 0.00% | – |
Q3 2020 | $16,000 | +700.0% | 446 | +271.7% | 0.00% | – |
Q3 2015 | $2,000 | -83.3% | 120 | -76.0% | 0.00% | – |
Q1 2015 | $12,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |